Posted 21 October, 2022
Prime Medicine, Inc. IPO completed
IPO completed detected for ticker Nasdaq:PRME in a 424B4 filed on 21 October, 2022.
This is an initial public offering of shares of common stock by Prime Medicine, Inc.
Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of Prime Medicine, Inc.
Health Care/Life Sciences • Biotechnology
Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.Market Cap
$1.05B
View Company Details
$1.05B
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.